fda warning letters compounding semaglutide october 2025 issued 25 to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Compounded "semaglutide" is not FDA-approved

Pioneer transcription factors, including OCT4, NANOG, and SOX2, initiate chromatin remodeling and activate embryonic gene expression programs that are essential for pluripotency maintenance and developmental progression

Retatrutide is sometimes called a "triple G" drug because it aims to activate the bodys receptors for those three G-word hormones

Image Credit: zimmytws / Shutterstock In a recent study published in the journal Diabetes, Obesity, and Metabolism , researchers evaluated clinical outcomes with oral semaglutide treatment in type 2 diabetes (T2D) patients

In 2025, the KFF Health Tracking Poll reported that about 1 in 8 U.S

Additionally, increasing healthcare infrastructure, rising awareness about metabolic diseases, and supportive government policies are boosting market growth

The first one or two shots will not give you that immediate improvement you might expect